Our Partners

RSS Investor Relations and News

  • MYOS RENS Technology Signs Distribution Agreement with National Sales Associates, LLC April 04, 2019
    Yolked® and MYOS Canine Muscle Formula® to be Distributed Nationwide CEDAR KNOLLS, N.J., April 4, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean [...]
    MYOS RENS Technology Reports Fourth Quarter and Fiscal 2018 Results March 28, 2019
    Conference Call to be Held Thursday, March 28, 2019 , at 11am ET CEDAR KNOLLS, N.J., March 28, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, [...]
    Learn More ›
  • MYOS RENS Technology Fourth Quarter 2018 Results Conference Call

    A digital replay of the Earnings Call is available by telephone until June 30, 2019 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, using the Conference ID# 13689169.

    The webcast is archived and available through April 11, 2019.

    North American Veterinary Community (NAVC) / VMX Conference

    Orlando Convention Center, Orlando, Florida

    • Please visit us at Booth #2381 and the Start-Up Circle S7 at the NAVC / VMX show featuring Myos Canine Muscle Formula.

    January 20, 2019 at 3:15 pm ET North American Veterinary Community (NAVC) / VMX, at the Discovery Theater, Orlando Convention Center, Orlando, Florida

    • Dr. Kenneth R. Harkin will present "The Impact of Fortetropin® Supplementation on Dogs Recovering from Tibial-Plateau Leveling Osteotomy (TPLO) Surgery"

Stock Snapshot

MYOS Symbol
NASDAQ Market
Market Cap
Price
Change
Volume